ANNIE: fixAtion of skiN Flaps After Mastectomy Using ruNning or Interrupted suturEs for Combatting Seroma

Sponsor
Zuyderland Medisch Centrum (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05941351
Collaborator
(none)
361
1
2
25.9
13.9

Study Details

Study Description

Brief Summary

Rationale: Flap fixation significantly reduces the incidence of seroma formation after mastectomy. Therefore, research should focus on finding the most optimal way to secure the skin flaps to the pectoral muscle. Previous studies have compared running sutures, interrupted sutures and tissue glue application to conventional wound closure. A recent systematic review with network meta-analysis indicated running sutures as the most optimal technique, however direct comparisons and high quality articles were lacking.

Objective: This prospective trial aims to directly compare running sutures with interrupted sutures in order to prevent complications in patients undergoing a mastectomy.

Study design: This trial will combine a retrospective cohort from the previous SARA-trial in Zuyderland MC with a randomised prospective trial. This study design was chosen to acquire a sample size with sufficient power and the ability to conduct this study in an acceptable time frame.

Study population: A retrospective cohort of patients participating in the SARA trial (RCT) and a prospective cohort of patients undergoing a mastectomy for breast cancer.

Intervention: Group 1: Flap fixation after mastectomy with running sutures. Group 2: Flap fixation after mastectomy with interrupted sutures.

Main study parameters/endpoints: The primary endpoint is the incidence of complications requiring interventions in both groups, including clinically significant seroma, infections and bleeding complications. Secondarily, the length of the procedure and cosmetic results will be compared.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: When participating, patients will undergo 3 additional outpatient clinic visits. Study visits will be combined with regular visits where possible, including the first postoperative visit after 7-10 days and either the 6 week or 3 month visit.

Condition or Disease Intervention/Treatment Phase
  • Procedure: flap fixation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
361 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
fixAtion of skiN Flaps After Mastectomy Using ruNning or Interrupted suturEs for Combatting Seroma
Anticipated Study Start Date :
Jan 1, 2025
Anticipated Primary Completion Date :
Jan 1, 2027
Anticipated Study Completion Date :
Mar 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Other: Running

Group 1: Flap fixation after mastectomy with running sutures.

Procedure: flap fixation
flap fixation using running or interrupted sutures

Other: Individual

Group 2: Flap fixation after mastectomy with interrupted sutures.

Procedure: flap fixation
flap fixation using running or interrupted sutures

Outcome Measures

Primary Outcome Measures

  1. Complications requiring an intervention [3 months]

    The main study parameter is the incidence of complications requiring interventions in both groups. This consists of: Clinically significant seroma, requiring aspirations in the case of: Pain or discomfort for the patient caused by large amounts of seroma characterised by tenderness of the skin. Signs of infection (redness, swelling, pain). Signs of delayed wound healing (wound breakdown, necrosis, seroma leakage). Surgical site infections, requiring oral/iv antibiotics or surgical drainage. Bleeding complications, requiring re-intervention, aspiration or surgical debridement.

Secondary Outcome Measures

  1. Surgery time [during surgery]

    surgery time in minutes

  2. Cosmetic outcome [3 months]

    • Cosmetic results measured using a numeric rating score (NRS) from 0-10, in which 0 equals very dissatisfied with the cosmetic results and 10 equals very satisfied with the results.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Female sex.

  • 18 years or older.

  • Indication for mastectomy.

Exclusion Criteria:
  • Patients undergoing breast conserving therapy

  • Patients undergoing direct breast reconstruction

  • Patients undergoing modified radical mastectomy

  • Unable to comprehend implications and extent of study and sign for informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Zuyderland MC Sittard Limbrug Netherlands 6162BG

Sponsors and Collaborators

  • Zuyderland Medisch Centrum

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Zuyderland Medisch Centrum
ClinicalTrials.gov Identifier:
NCT05941351
Other Study ID Numbers:
  • METCZ20230049
First Posted:
Jul 12, 2023
Last Update Posted:
Jul 12, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 12, 2023